What is the treatment for vitiligo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Vitiligo

The first-line treatment for vitiligo is potent or very potent topical corticosteroids for limited areas, with narrowband UVB phototherapy recommended for widespread disease. 1

First-Line Treatments

Topical Therapies

  • Topical Corticosteroids

    • Recommended as first-line therapy for limited areas of vitiligo 2, 1
    • Apply a thin layer twice daily for no more than 2 consecutive weeks 3
    • Maximum 50g per week should not be exceeded 3
    • Treatment should be limited to 2 months, with application on alternate weeks 1
    • Efficacy: Up to 80% repigmentation in facial lesions and 40% in other body areas 1
    • Monitor for skin atrophy, a common side effect 1
  • Topical Calcineurin Inhibitors (Tacrolimus, Pimecrolimus)

    • Alternative to topical steroids, especially for facial areas and in children 1
    • Better safety profile than potent steroids (no skin atrophy) 2, 1
    • Particularly effective for facial lesions and in darker skin types 1
    • May cause stinging as a side effect 2

Phototherapy

  • Narrowband UVB (NB-UVB)
    • Preferred phototherapy option for widespread vitiligo 1
    • Superior efficacy and safety compared to PUVA 2, 1
    • Maximum 200 treatments for skin types I-III 1
    • Especially beneficial for darker skin types 1

Second-Line Treatments

Combination Therapies

  • Topical Agents + Phototherapy
    • Combining topical treatments with NB-UVB often yields better results than monotherapy 1
    • Tacrolimus with Excimer UV radiation enhances repigmentation for UV-sensitive sites 2
    • Topical betamethasone and calcipotriol combination may be more effective than either agent alone 2, 4

Surgical Options

  • Consider for stable vitiligo that hasn't responded to medical treatments 1
  • Options include:
    • Split-skin grafting
    • Autologous epidermal suspension
    • Suction blister transfer 1

Depigmentation

  • p-(benzyloxy)phenol (MBEH) may be considered for extensive vitiligo 1
  • Only for cases where repigmentation treatments have failed 5
  • Patients must accept permanent inability to tan 1

Treatment Algorithm

  1. For Limited Areas:

    • Start with potent topical corticosteroids twice daily for 2 weeks, then alternate weeks for up to 2 months 1, 3
    • For facial areas or in children, use topical calcineurin inhibitors instead 2, 1
    • If no improvement after 2 months, reassess diagnosis or move to next option 3
  2. For Widespread Disease:

    • Narrowband UVB phototherapy as primary treatment 1
    • Can be combined with topical agents for enhanced efficacy 1
  3. For Resistant Cases:

    • Consider combination therapies (e.g., topical agents + phototherapy) 1
    • Evaluate for surgical options if disease is stable 1
    • For extensive vitiligo recalcitrant to other treatments, consider depigmentation 1, 5

Important Considerations

  • Treatment response varies by anatomical location - face and neck respond better than hands and feet 1
  • Maintenance therapy should be considered to reduce relapse risk (>40% lose response after 1 year without treatment) 1
  • Psychological interventions should be offered to improve coping mechanisms 1
  • Treatment adherence is crucial - patients adhering to >75% of protocol are more likely to achieve success 1
  • Monitor response with serial clinical photographs every 2-3 months 1

Common Pitfalls to Avoid

  • Unrealistic Expectations: Educate patients that repigmentation is often slow and may be incomplete
  • Overuse of Topical Steroids: Strictly adhere to recommended duration to prevent skin atrophy 3
  • Neglecting Psychological Impact: Address the psychosocial burden of vitiligo alongside physical treatment 1
  • Inappropriate Treatment Selection: Consider anatomical location and skin type when selecting therapy 1
  • Premature Treatment Discontinuation: Emphasize that treatments may take months to show significant results

References

Guideline

Vitiligo Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Vitiligo: an update on current pharmacotherapy and future directions.

Expert opinion on pharmacotherapy, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.